You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Express Scripts
Boehringer Ingelheim
AstraZeneca
Colorcon

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Setipiprant

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Setipiprant?

Setipiprant is an investigational drug.

There have been 4 clinical trials for Setipiprant. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2011.

The most common disease conditions in clinical trials are Alopecia, Rhinitis, Allergic, Seasonal, and Rhinitis, Allergic. The leading clinical trial sponsors are Actelion, Allergan, and [disabled in preview].

There are twenty US patents protecting this investigational drug and two hundred and sixty-three international patents.

Recent Clinical Trials for Setipiprant
TitleSponsorPhase
Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in MalesAllerganPhase 2
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic RhinitisActelionPhase 3
A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)ActelionPhase 1

See all Setipiprant clinical trials

Clinical Trial Summary for Setipiprant

Top disease conditions for Setipiprant
Top clinical trial sponsors for Setipiprant

See all Setipiprant clinical trials

US Patents for Setipiprant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Setipiprant   Get Started for $10 Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Get Started for $10
Setipiprant   Get Started for $10 JAK inhibitors containing a 4-membered heterocyclic amide THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   Get Started for $10
Setipiprant   Get Started for $10 Fused imidazo-piperidine JAK inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   Get Started for $10
Setipiprant   Get Started for $10 Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN)   Get Started for $10
Setipiprant   Get Started for $10 Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN)   Get Started for $10
Setipiprant   Get Started for $10 JAK inhibitors containing a 4-membered heterocyclic amide THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)   Get Started for $10
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Setipiprant

Drugname Country Document Number Estimated Expiration Related US Patent
Setipiprant Australia AU2017261372 2036-05-05   Get Started for $10
Setipiprant Canada CA3023278 2036-05-05   Get Started for $10
Setipiprant China CN107847398 2036-05-05   Get Started for $10
Setipiprant European Patent Office EP3452003 2036-05-05   Get Started for $10
Setipiprant Hong Kong HK1249728 2036-05-05   Get Started for $10
Setipiprant Japan JP2019520866 2036-05-05   Get Started for $10
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Moodys
McKinsey
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.